Ramin Farzaneh-Far, Chief Medical Officer at Ra Pharmaceuticals, Inc. (RARX), sold 21,190 shares at $47.23 ($1.0M) on 2019-12-16, disclosed to the SEC on 2019-12-18.
Open-market sale of $1.0M RARX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.23 | 10,595 | $500K | 50.0% |
| 2 | $47.23 | 10,595 | $500K | 50.0% |
| Total | $47.23 avg | 21,190 | $1.0M | 100% |
| Filing → |
| RARX | SELL | 2020-01-16 | $995K | — | Filing → |
| RARX | SELL | 2019-11-18 | $989K | — | Filing → |
| RARX | SELL | 2019-10-17 | $994K | — | Filing → |